Literature DB >> 10023606

Zyban: a new aid to smoking cessation treatment--will it work for psychiatric patients?

C R Farnam1.   

Abstract

1. Psychiatric patients who smoke are more highly dependent on nicotine and are less likely to be successful at quitting. When they attempt to quit, depression is more likely to be a part of the withdrawal process. 2. Careful monitoring is required when psychiatric patients abruptly start or stop smoking. Clinicians must be aware that changes in smoking status will affect the actions and side effects of neuroleptic medications. Prescribing clinicians should ask about their patients' smoking patterns on a regular basis. 3. Psychiatric nurses have an ethical responsibility to identify individuals at risk of smoking-related disease, to inform current and future smokers about the risks of cigarette smoking, and to provide counseling and education for those who wish to quit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10023606

Source DB:  PubMed          Journal:  J Psychosoc Nurs Ment Health Serv        ISSN: 0279-3695            Impact factor:   1.098


  3 in total

1.  A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients.

Authors:  Hsing-Kang Chen; Tsuo-Hung Lan; Bo-Jian Wu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-23       Impact factor: 5.270

2.  Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders.

Authors:  Bo-Jian Wu; Tsuo-Hung Lan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-27       Impact factor: 5.270

3.  Effects of a tobacco ban on long-term psychiatric patients.

Authors:  Grant T Harris; Daniel Parle; Joseph Gagné
Journal:  J Behav Health Serv Res       Date:  2006-12-19       Impact factor: 1.505

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.